Modus Therapeutics Holding AB (FRA:99Z) Change In Inventory : €0.00 Mil (TTM As of Sep. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Modus Therapeutics Holding AB Change In Inventory?

Modus Therapeutics Holding AB's change in inventory for the quarter that ended in Sep. 2024 was €0.00 Mil. It means Modus Therapeutics Holding AB's inventory stayed the same from Jun. 2024 to Sep. 2024 .

Modus Therapeutics Holding AB's change in inventory for the fiscal year that ended in Dec. 2023 was €0.00 Mil. It means Modus Therapeutics Holding AB's inventory stayed the same from Dec. 2022 to Dec. 2023 .

Modus Therapeutics Holding AB's Total Inventories for the quarter that ended in Sep. 2024 was €0.00 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Inventory Turnover measures how fast the company turns over its inventory within a year.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Modus Therapeutics Holding AB Change In Inventory Historical Data

The historical data trend for Modus Therapeutics Holding AB's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Modus Therapeutics Holding AB Change In Inventory Chart

Modus Therapeutics Holding AB Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Inventory

Modus Therapeutics Holding AB Quarterly Data
	Dec19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Change In Inventory	Get a 7-Day Free Trial														-	-	-	-	-

Modus Therapeutics Holding AB Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Modus Therapeutics Holding AB (FRA:99Z) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Modus Therapeutics Holding AB's Days Inventory for the quarter that ended in is calculated as:

Days Inventory	=	Average Total Inventories	/	Cost of Goods Sold	*	Days in Period
	=	0	/	0	*	365 / 4
	=	N/A

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

Modus Therapeutics Holding AB's Inventory Turnover for the quarter that ended in Sep. 2024 is calculated as

Inventory Turnover	=	Cost of Goods Sold	/	Average Total Inventories
	=	0	/	0
	=	N/A

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Modus Therapeutics Holding AB's Inventory to Revenue for the quarter that ended in Sep. 2024 is calculated as

Inventory-to-Revenue	=	Average Total Inventories	/	Revenue
	=	0	/	0
	=	N/A

Modus Therapeutics Holding AB Change In Inventory Related Terms

Thank you for viewing the detailed overview of Modus Therapeutics Holding AB's Change In Inventory provided by GuruFocus.com. Please click on the following links to see related term pages.

Modus Therapeutics Holding AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Modus Therapeutics Holding AB (FRA:99Z) » Definitions » Change In Inventory

Comparable Companies

Traded in Other Exchanges

MODTX:Sweden

Address

Olof Palmes gata 29 IV, Stockholm, SWE, 111 22

Website

https://www.modustx.com

Modus Therapeutics Holding AB is a Swedish clinical biotechnology company developing a treatment for sepsis, endotoxemia, severe malaria, and other disorders with severe systemic inflammation as well as states of anemia, related to chronic inflammation such as kidney diseases through its patented polysaccharide sevuparin. The drug candidate sevuparin has the opportunity to benefit patients and save large healthcare costs.

Modus Therapeutics Holding AB Headlines

No Headlines